133 related articles for article (PubMed ID: 12941090)
1. Analytic quantification of solar lentigines lightening by a 2% hydroquinone-cyclodextrin formulation.
Petit L; Piérard GE
J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):546-9. PubMed ID: 12941090
[TBL] [Abstract][Full Text] [Related]
2. Assessment of topical hypopigmenting agents on solar lentigines of Asian women.
Hermanns JF; Petit L; Piérard-Franchimont C; Paquet P; Piérard GE
Dermatology; 2002; 204(4):281-6. PubMed ID: 12077522
[TBL] [Abstract][Full Text] [Related]
3. Analytic quantification of the bleaching effect of a 4-hydroxyanisole-tretinoin combination on actinic lentigines.
Piérard-Franchimont C; Henry F; Quatresooz P; Vroome V; Piérard GE
J Drugs Dermatol; 2008 Sep; 7(9):873-8. PubMed ID: 19112802
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of hydroquinone-free skin-lightening cream for photoaging.
Dreher F; Draelos ZD; Gold MH; Goldman MP; Fabi SG; Puissegur Lupo ML
J Cosmet Dermatol; 2013 Mar; 12(1):12-7. PubMed ID: 23438137
[TBL] [Abstract][Full Text] [Related]
5. Triple combination as adjuvant to cryotherapy in the treatment of solar lentigines: investigator-blinded, randomized clinical trial.
Hexsel D; Hexsel C; Porto MD; Siega C
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):128-33. PubMed ID: 24684165
[TBL] [Abstract][Full Text] [Related]
6. Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines.
Jarratt M
Cutis; 2004 Nov; 74(5):319-22. PubMed ID: 15605971
[TBL] [Abstract][Full Text] [Related]
7. Follow-up of solar lentigo depigmentation with a retinaldehyde-based cream by clinical evaluation and calibrated colour imaging.
Questel E; Durbise E; Bardy AL; Schmitt AM; Josse G
Skin Res Technol; 2015 May; 21(2):241-6. PubMed ID: 25078981
[TBL] [Abstract][Full Text] [Related]
8. Analytic assessment under ultraviolet light of actinic lentigines under bleaching treatment.
Piérard GE; Seité S; Rougier A; Quatresooz P
J Cosmet Dermatol; 2011 Jun; 10(2):104-9. PubMed ID: 21649815
[TBL] [Abstract][Full Text] [Related]
9. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
[TBL] [Abstract][Full Text] [Related]
10. Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial.
Kang S; Goldfarb MT; Weiss JS; Metz RD; Hamilton TA; Voorhees JJ; Griffiths CE
J Am Acad Dermatol; 2003 Jul; 49(1):83-90. PubMed ID: 12833014
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation.
Makino ET; Mehta RC; Banga A; Jain P; Sigler ML; Sonti S
J Drugs Dermatol; 2013 Mar; 12(3):s16-20. PubMed ID: 23545928
[TBL] [Abstract][Full Text] [Related]
12. Comparison of trichloroacetic acid solution and cryosurgery in the treatment of solar lentigines.
Lugo-Janer A; Lugo-Somolinos A; Sanchez JL
Int J Dermatol; 2003 Oct; 42(10):829-31. PubMed ID: 14521703
[TBL] [Abstract][Full Text] [Related]
13. The combination of 2% 4-hydroxyanisole (Mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies.
Fleischer AB; Schwartzel EH; Colby SI; Altman DJ
J Am Acad Dermatol; 2000 Mar; 42(3):459-67. PubMed ID: 10688717
[TBL] [Abstract][Full Text] [Related]
14. A Role for NRF2-Signaling in the Treatment and Prevention of Solar Lentigines.
Kerns ML; Chien AL; Kang S
Plast Reconstr Surg; 2021 Dec; 148(6S):27S-31S. PubMed ID: 34847095
[TBL] [Abstract][Full Text] [Related]
15. A Prospective Trial Comparing Q-Switched Ruby Laser and a Triple Combination Skin-Lightening Cream in the Treatment of Solar Lentigines.
Imhof L; Dummer R; Dreier J; Kolm I; Barysch MJ
Dermatol Surg; 2016 Jul; 42(7):853-7. PubMed ID: 27341683
[TBL] [Abstract][Full Text] [Related]
16. Comparative morphometric study of eruptive PUVA-induced and chronic sun-induced lentigines of the skin.
Nikkels A; Ben Mosbah T; Piérard-Franchimont C; de la Brassinne M; Piérard GE
Anal Quant Cytol Histol; 1991 Feb; 13(1):23-6. PubMed ID: 2025370
[TBL] [Abstract][Full Text] [Related]
17. Environment-induced lentigines: formation of solar lentigines beyond ultraviolet radiation.
Nakamura M; Morita A; Seité S; Haarmann-Stemmann T; Grether-Beck S; Krutmann J
Exp Dermatol; 2015 Jun; 24(6):407-11. PubMed ID: 25777082
[TBL] [Abstract][Full Text] [Related]
18. Human in vivo and in vitro hydroquinone topical bioavailability, metabolism, and disposition.
Wester RC; Melendres J; Hui X; Cox R; Serranzana S; Zhai H; Quan D; Maibach HI
J Toxicol Environ Health A; 1998 Jun; 54(4):301-17. PubMed ID: 9638901
[TBL] [Abstract][Full Text] [Related]
19. Clinical and instrumental evaluation of the efficacy of a new depigmenting agent containing a combination of a retinoid, a phenolic agent and an antioxidant for the treatment of solar lentigines.
Cameli N; Abril E; Agozzino M; Mariano M
Dermatology; 2015; 230(4):360-6. PubMed ID: 25871836
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of red orange extract supplementation against UV-induced skin damages: photoaging and solar lentigines.
Puglia C; Offerta A; Saija A; Trombetta D; Venera C
J Cosmet Dermatol; 2014 Jun; 13(2):151-7. PubMed ID: 24910279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
